Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 4113

European drug regulator reverses opinion on Eisai and Biogen's Alzheimer's drug

$
0
0
The European Medicines Agency has flipped its stance on Eisai and Biogen’s Alzheimer’s treatment Leqembi, recommending authorization in a narrower population than it previously considered. The agency's human medicines committee, also known as CHMP, issued ...

Viewing all articles
Browse latest Browse all 4113

Latest Images

Trending Articles



Latest Images